EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondria‐Targeted Nanomotor: H 2 S‐Driven Cascade Therapy for Hepatocellular Carcinoma

Chengcheng Li iD, Xiaodong Ma, Shiji Fang, Biao Chen, Xinru Wang, Lingyun He, Xin Yang, Yuanqiang Li, Jessica M Rosenholm, Zhongwei Zhao, Jiansong Ji, Hongbo Zhang iD

Advanced Materials · 2026-02 · 38 (8)

DOI: 10.1002/adma.202513757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 01.12.2025. Verfasst von Chengcheng Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biote…. Hauptthemen laut MEDLINE: Hydrogen Sulfide, Carcinoma, Hepatocellular, Liver Neoplasms, Mitochondria. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Project, Solution for Health Profile, InFLAMES Flagship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advances in combination therapies for cancer treatment, most strategies rely on modular‐additive designs that lack dynamic molecular cues to achieve intrinsic synergy. Herein, a mitochondrial‐targeted nanoplatform is introduced that orchestrates photodynamic therapy (PDT), mild photothermal therapy (mPTT), and enzyme dynamic therapy (EDT) into a self‐amplifying cascade network through gasotransmitter (H 2 S)‐driven metabolic reprogramming. It is constructed from an Au 2 Pt core with a surface functionalized mesoporous silica shell loaded with photosensitizers, encapsulated within a tumor cell membrane (Au 2 Pt@4sMSN/PS‐TPP@CM). Upon GSH exposure, nanomotors produce H 2 S to boost diffusive motion, while TPP targeting directs this motility toward mitochondria, enabling efficient mitochondrial accumulation (internalization of >100 nm nanoparticles). Subsequently, mitochondrial targeted H 2 S releasing‐mediated suppression of oxidative phosphorylation amplifies PDT efficacy; HSP70 downregulation enables mPTT; and hyperactive glycolytic metabolism fuels EDT. Furthermore, these enhanced modalities also interconnect in a positive feedback loop: mPTT‐derived hyperthermia accelerates EDT‐catalyzed oxygen generation for PDT, while mitochondria‐localized PDT further inhibits HSP70 to boost mPTT. Ultimately, these interconnected molecular cues establish an H 2 S‐driven, self‐reinforcing therapeutic loop that enables effective eradication of hepatocellular carcinoma. Collectively, this study identifies mitochondria as the biological initiator and signal integrator for multimodal therapy, delivering a distinctive paradigm to overcome the limitations of conventional combination therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydrogen SulfideCarcinoma, HepatocellularLiver NeoplasmsMitochondriaNanoparticlesHumansPhotochemotherapyPhotosensitizing AgentsAnimalsCell Line, TumorGoldSilicon DioxideMiceHSP70 Heat-Shock Proteins

Stichwörter der Autor:innen

cascade therapyenzyme dynamic therapymitochondria‐targetingphotodynamic therapyphotothermal therapy

Substanzen

Hydrogen SulfidePhotosensitizing AgentsGoldSilicon DioxideHSP70 Heat-Shock Proteins

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, Department of Radiology, Lishui Central Hospital, The Fifth…
  • Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, Turku, 20500, Finland.
  • Joint Centre of Translational Medicine, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
  • Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, 20520, Finland.

ORCID-Profile: Chengcheng Li, Hongbo Zhang

Förderung

  • Research Project
  • Solution for Health Profile
  • InFLAMES Flagship
  • Research Council of Finland; Natural Science Foundation of Zhejiang Province
  • Zhejiang Provincial Natural Science Foundation of China
  • Chengcheng Li

Zitieren

APA

Li, C., Ma, X., Fang, S., Chen, B., Wang, X., He, L., Yang, X., Li, Y., Rosenholm, J. M., Zhao, Z., Ji, J., & Zhang, H. (2026). Mitochondria‐Targeted Nanomotor: H 2 S‐Driven Cascade Therapy for Hepatocellular Carcinoma. Advanced Materials, 38(8). https://doi.org/10.1002/adma.202513757

Vancouver

Li C, Ma X, Fang S, Chen B, Wang X, He L, et al. Mitochondria‐Targeted Nanomotor: H 2 S‐Driven Cascade Therapy for Hepatocellular Carcinoma. Advanced Materials. 2026;38(8). doi:10.1002/adma.202513757

BibTeX
@article{Li2026,
  author = {Li, Chengcheng and Ma, Xiaodong and Fang, Shiji and Chen, Biao and Wang, Xinru and He, Lingyun and Yang, Xin and Li, Yuanqiang and Rosenholm, Jessica M and Zhao, Zhongwei and Ji, Jiansong and Zhang, Hongbo},
  title = {Mitochondria‐Targeted Nanomotor: H 2 S‐Driven Cascade Therapy for Hepatocellular Carcinoma},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {8},
  doi = {10.1002/adma.202513757}
}
Kostenlos starten →